Dr Ray qualified from Oxford University and Guy’s, King’s and St Thomas’ School of Medicine. He received a BHF scholar award and a BHF clinical PhD studentship and completed a PhD at King’s College Hospital, London in endothelial function, blood pressure and heart failure. He trained on the South East London Cardiology rotation and completed a cardiac imaging fellowship at the Brompton Hospital. He joined St George’s Hospital as a consultant in heart failure and cardiac imaging and honorary senior lecturer in 2015.

Clinical interests 

General Cardiology, Heart failure and Cardiac Imaging (Cardiac Magnetic Resonance Imaging and Echocardiography). Dr Ray was one of three consultants who developed and implemented the first national Acute Heart Failure Unit in the UK which opened at St George’s Hospital in 2016. This provides specialist nursing, therapist and cardiology care to patients with heart failure. 

Membership/affiliations 

• Fellow of the Royal College of Physicians

• Fellow of the Heart failure association

• British Heart failure society

• British Cardiac Society

• European Society of Cardiology

• British society of echocardiography (BSE)

• British society of cardiovascular imaging (BSCI)

• Royal society of medicine (RSM)

• European Association for Cardiovascular Prevention and Rehabilitation (EACPR)

Dr Ray has on going research interests in acute heart failure and iron deficiency anaemia and has been the Chief Investigator and Principal investigator of a number of acute heart failure trials. He is also an Associate Editor of the European Cardiology Review journal.

Dr Ray has obtained an HEE (Health Education England) grant to introduce person-centred care to the heart failure unit at St George’s to improve patient experience and provide a centre of excellence to train heart failure nurses and fellows.

• Chief investigator for SoMoR 2018-2019

• Principal investigator for clinical research trials: AFFIRM-AHF, IRONMAN, RELAX EU study Novartis RLX030A3301

• UK coordinating co-principal investigator for ATTR-ACT: Phase 3 multinational trial to Evaluate the Efficacy and Safety of the Transthyretin stabiliser Tafamidis in the treatment of Transthyretin Cardiomyopathy (TTR-CM).

• Co-Principal investigator for ENDEAVOUR a Phase 3 multinational trial to Evaluate the Efficacy and Safety of ALN TTRSC in Patients with Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC).

• UK Coordinating co-principal investigator for DISCOVERY.

Kumar and Clark's Clinical Medicine 9ed 2019 Cardiology chapter Robin Ray & Nicholas Bunce 

Seferović PM et al. Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Sep;22(9):1495-1503. doi: 10.1002/ejhf.1954. Epub 2020 Aug 5. PMID: 32618086.

Seferović et al. Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure. Eur J Heart Fail. 2020 Nov;22(11):1984-1986. doi: 10.1002/ejhf.2026. Epub 2020 Oct 27. PMID: 33068051.

Alakbarzade V, Keteepe-Arachi T, Karsan N, Ray R & Pereira A; Patent Foramen Ovale: what neurologists need to know Practical Neurology (2020) Patent foramen ovale  Practical Neurology 2020 May;20(3):225-233. 

Maurer MS et al.; ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. 

ACCA European Society of Cardiology e-learning platform 2014. Chapter 53. Acute heart failure: early pharmacological treatment

End-stage heart failure: Cardiac transplantation, LVAD and palliative care. Oxford handbook of heart failure 2009 Chapter 11

Core Topics in preoperative anaesthetic assessment and management. Cardiac Imaging. Cambridge University Press 2016 (in press) Crerar-Gilbert et al.

Robin Ray & John Chambers. Mitral valve disease. Int J Clin Pract. 2014 Oct;68(10):1216-20.

ACCA European Society of Cardiology e-learning platform 2014. Chapter 20. Echocardiography and thoracic ultrasound

Mabrouk-Zerguini et al. Tei index to assess perioperative left ventricular systolic function in patients undergoing mitral valve repair. Br J Anaesth. 2008;101:479-85.

Pavitt et al. Deriving coronary artery calcium scores from CT coronary angiography: a proposed algorithm for evaluating stable chest pain. Int J Cardiovasc Imaging. 2014;30:1135-43

Robin Ray et al. An Unusual Case of Ventricular ectopy in a military pilot Aviat Space Environ Med. 2014;85:462-5

Robin Ray et al. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo.  ATVB 2011; 31: 1368-1376.

Dworakowski et al. Experimental hyperlipidaemia does not prevent preconditioning and it reduces ischemia-induced apoptosis. Int J Cardiol. 2008;126:62-7.

Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond). 2005;109:217-26.

Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM.

NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal. 2006 (5-6):691-728.

Dr Ray is passionate about education which has been a core part of his portfolio, including a number of local, national and international roles in both undergraduate and post-graduate medical education. He has sat on the Royal College of Physicians Education committee, British cardiac society education committee and was appointed as a member of the Educational committee on the European Heart Failure Association in 2017.

He has a strong interest in simulation and has developed a number of cardiology simulation courses focusing on interpersonal communication skills and multi-disciplinary team-working. He has also set up communication skills courses and clinical MRCP PACES courses for the training of junior doctors.